research

A scientist’s opinion: Interview with Professor Giovanni Rezza on tackling the Covid-19 pandemic

A scientist’s opinion : Interview with Professor Giovanni Rezza on tackling the Covid-19 pandemic

Tackling the Covid-19 pandemic, a scientist’s opinion We speak with Professor Giovanni Rezza, MD, Director of the Department of Infectious Diseases at the Istituto Superiore di Sanità, Roma, Italy about the EU’s announcement of funding for research to tackle Covid-19, and current efforts to develop vaccines and antiviral drugs. How prepared was the EU for ...

A scientist’s opinion: Interview with Professor Paul Digard on research efforts to develop treatments against Covid-19

A scientist’s opinion : Interview with Professor Paul Digard on research efforts to develop treatments against Covid-19

Research efforts to develop treatments against Covid-19 Professor Paul Digard, virologist at The Roslin Institute, University of Edinburgh, tells us about potential routes to Covid-19 treatment and the prospect of having to deal with the virus long-term. How soon do you think a vaccine against Covid-19 will be available? I can’t see a vaccine being ...

A scientist’s opinion : Interview with Aroon Hingorani about re-engineering pharmaceutical research

A scientist’s opinion : Interview with Aroon Hingorani about re-engineering pharmaceutical research

Re-engineering pharmaceutical research, a scientist’s opinion Interview with Aroon Hingorani, Professor of Genetic Epidemiology at University College London. Could you speculate what you think are the biggest causes of drug failure? It is well recognised that the number one cause for drug failure is a lack of efficacy of the drug in the intended indication, ...

A scientist’s opinion : Interview with Dr Denis Lacombe about re-engineering pharmaceutical research

A scientist’s opinion : Interview with Dr Denis Lacombe about re-engineering pharmaceutical research

Re-engineering pharmaceutical research, a scientist’s opinion Interview with Dr Denis Lacombe, Director General of the European Organisation for Research and Treatment of Cancer (EORTC). Can you tell me a bit about the European Organisation for Research and Treatment of Cancer (EORTC)? We are a non-governmental, not-for-profit organisation established for 60 years, focusing on survival and ...

Re-engineering pharmaceutical research for better patient outcomes

Re-engineering pharmaceutical research for better patient outcomes

A so-called ‘productivity crisis’ has been ascribed to the pharmaceutical research and development industry. Despite increases in investment and funding, this has not corresponded to increases in the approval of novel drugs. Why do so many drugs fail to receive approval, and what other means should we be focusing on for the benefit of patients?

A scientist’s opinion : Interview with Dr Síle Lane about re-engineering pharmaceutical research

A scientist’s opinion : Interview with Dr Síle Lane about re-engineering pharmaceutical research

Re-engineering pharmaceutical research, a scientist’s opinion Interview with Dr Síle Lane, head of international campaigns and policy at Sense About Science. Undisclosed clinical trial results are unfortunately common - how does this impact progression in research and treatment? When results from clinical trials aren’t published it means the same research can get repeated unnecessarily. This ...

White smart phone on a wooden table emitting holographic image of social media related icons. Blurred city background.

SOMA consortium scales up anti-disinformation efforts across EU Member States

Horizon-2020-supported Social Observatory for Disinformation and Social Media Analysis links academic, technological and media expertise to combat disinformation.

#Tekoälyaika – Finland’s 1% AI education strategy

#Tekoälyaika – Finland’s 1% AI education strategy

Finland became the first country in the world offering AI education to the general public. The objective: free AI education for 1% of the population. What is Finland’s aim and will EU countries be able to follow suit in democratising AI and reinforce civic education?

ESMH Online disinformation during elections

Online disinformation during elections : researchers in Europe team up to monitor and analyse the situation

As has been the case for many recent national elections, the European Parliament elections are also facing the challenges of online disinformation. The European Commission is making an extra effort to push giant tech companies to implement a voluntary code of conduct against disinformation. European researchers are preparing the first studies on the topic.

Autonomous cars : will roads be safer if algorithms replace human drivers?

Autonomous cars : will roads be safer if algorithms replace human drivers?

Research on autonomous cars has received a boost from the European Parliament, but the technology still raises many questions. Can it be safe and ethical? Will it totally eliminate the need for human drivers? And, of course: when will this happen?